PONESIMOD | PONESIMOD | ATC L04AA50
IMMUNOMODULATING IMMUNOSUPPRESSANT SPHINGOSINE1-PHOSPHATE (S1P) RECEPTOR 1 MODULATOR TREATMENT OF RELAPSING FORMS OF MULTIPLE SCLEROSIS (MS) | ORAL | Tmax 3 HOUR F 84 PERCENT VD 160 LITER PPB 99 PERCENT Cl 3.8 LITER / HOUR HT 33 HOUR SOLUBILITY PACTICALLY INSOLUBLE IN WATER | SPHINGOSINE1-PHOSPHATE (S1P) RECEPTOR 1 | Unknown - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |